Oncology Center, The Affiliated Jiangsu Shengze Hospital of Nanjing Medical University, Wujiang, Jiangsu 215228, China.
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Comput Math Methods Med. 2022 Dec 8;2022:3764914. doi: 10.1155/2022/3764914. eCollection 2022.
Fatty acid binding protein 4 (FABP4) is mainly involved in the regulation of systemic metabolism through various lipid signaling pathways. Metabolic reprogramming is one of the important factors in the development and progression of cancer. It has been recently reported that FABP4 is closely related to the development of cancer and may be involved in tumor invasion and metastasis.
In this study, we explored the expression pattern of FABP4 in pancancer through TCGA and CPTAC. Using TCGA, Kaplan-Meier Plotter, and STRING databases, to explore its diagnostic and prognostic value, and function through GO/KEGG and GSEA. Then, using the TIMER2.0 database, we investigated the correlation between FABP4 expression and immune infiltration in cancers, especially stomach adenocarcinomas (STAD) and colorectal adenocarcinoma (COADREAD).
Compared with normal tissues, the expression of FABP4 in more than 10 tumor tissues was lower ( < 0.05). Through the receiver operating characteristic (ROC) curve, the diagnostic value was found higher in colorectal cancer, breast cancer, thyroid cancer, and lung cancer, with the area under the curve (AUC) > 0.9. Through the K-M curve, FABP4 was found to correlate to the prognosis of various cancers. The results of gastric cancer and colorectal cancer are consistent. The low-expression group has a better prognosis than the high-expression group, and the expression of FABP4 in the early T and N stages of gastrointestinal tumors is lower. FABP4 highly expressed gene set is mostly enriched in extracellular matrix degradation and cell adhesion functions. Gastrointestinal tumors with high expression of FABP4 may have more immunosuppressive effects on macrophages and have a worse prognosis.
FABP4 can be used as a diagnostic and prognostic biomarker in pancancer, and its high expression in gastrointestinal tumors suggests poor prognosis. This may be correlated to the immune infiltration of macrophages and epithelial-mesenchymal transition.
脂肪酸结合蛋白 4(FABP4)主要通过各种脂质信号通路参与全身代谢的调节。代谢重编程是癌症发生和发展的重要因素之一。最近有报道称,FABP4 与癌症的发生发展密切相关,可能参与肿瘤的侵袭和转移。
本研究通过 TCGA 和 CPTAC 探讨了 FABP4 在泛癌中的表达模式。利用 TCGA、Kaplan-Meier Plotter 和 STRING 数据库,探索其诊断和预后价值,并通过 GO/KEGG 和 GSEA 进行功能分析。然后,利用 TIMER2.0 数据库,研究了 FABP4 表达与癌症,尤其是胃腺癌(STAD)和结直肠癌(COADREAD)中免疫浸润的相关性。
与正常组织相比,10 多种肿瘤组织中 FABP4 的表达较低(<0.05)。通过受试者工作特征(ROC)曲线,发现 FABP4 在结直肠癌、乳腺癌、甲状腺癌和肺癌中的诊断价值较高,曲线下面积(AUC)>0.9。通过 K-M 曲线,发现 FABP4 与多种癌症的预后相关。胃癌和结直肠癌的结果一致。低表达组的预后优于高表达组,且胃肠道肿瘤的早期 T 期和 N 期 FABP4 表达较低。FABP4 高表达基因集主要富集在细胞外基质降解和细胞黏附功能。FABP4 高表达的胃肠道肿瘤可能对巨噬细胞具有更强的免疫抑制作用,预后较差。
FABP4 可作为泛癌的诊断和预后生物标志物,其在胃肠道肿瘤中的高表达提示预后不良。这可能与巨噬细胞的免疫浸润和上皮间质转化有关。